Clinical Trials@2x
  • News

    Most Read

    • Pharm-Olam to support Adalimumab COVID Therapeutic Trial
    • BioEclipse starts enrolment in Phase I refractory solid tumour trial
    • Bioclinica unveils ‘Image Redact AI’ solution for clinical trials

    Most Recent

    Clinical Trials

    Pharm-Olam to support Adalimumab COVID Therapeutic Trial

    20 Jan 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy
    • Teva and MedinCell Looking to Enter Increasingly Competitive LAI Schizophrenia Market
    • Novo Nordisk’s makes strides into Alzheimer’s with anti-diabetic drug

    Most Recent

    Clinical Trials

    Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy

    12 Jan 2021
  • Sectors

    Sections

    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices

    Most Read

    • Pharm-Olam to support Adalimumab COVID Therapeutic Trial
    • BioEclipse starts enrolment in Phase I refractory solid tumour trial
    • Bioclinica unveils ‘Image Redact AI’ solution for clinical trials

    Most Recent

    Clinical Trials

    Pharm-Olam to support Adalimumab COVID Therapeutic Trial

    20 Jan 2021
  • Themes
  • Deals

    Most Read

    • Investment firm GI Partners closes Clinical Ink acquisition
    • Investment firm GI Partners to acquire minority interest in Clinical Ink
    • IVI and SNU partner to trial Inovio’s Covid-19 vaccine in Korea

    Most Recent

    Clinical Trials

    Investment firm GI Partners closes Clinical Ink acquisition

    27 Aug 2020
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Linari NanoTech
    • OpenClinica
    • Strategikon Pharma

    Most Recent

    Linari NanoTech

    19 Jan 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register

 

21 Dec 2020
Accelerating Clinical Trials

The benefit of running clinical trials in Asia-Pacific for biotech companies

21 Dec 2020
28 Oct 2020
Sponsored

Translating Documentation and Communication in Clinical Research – Virtual Conference

28 Oct 2020
26 Aug 2020
Sponsored

How collaboration and secure data transfer is transforming clinical trials

26 Aug 2020
03 Aug 2020
Sponsored

How biotechs can tap APAC for excellence in oncology trials

03 Aug 2020
06 Jul 2020
Sponsored

Why Asia-Pacific attracts 60% of all ongoing and planned hepatology trials globally

06 Jul 2020
10 Mar 2020
Sponsored

Clinical trials data report for Asia-Pacific: Frost & Sullivan collaborates with Novotech

10 Mar 2020
21 Feb 2020
Sponsored

Novotech case study: Global reach through CRO partnership for a phase 2 oncology trial

21 Feb 2020

Join Our Newsletter

Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Clinical Trials

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more